SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2013 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Biotech Jim12/31/2012 12:08:23 PM
  Read Replies (1) of 410
 
Here are my picks for 2013:

ACAD 10%
Pimavanserin for Parky psychosis and the second Ph3 trial will be the key

CCXI 10%
Several chemokine receptor antagonists to have news flow, committed GSK as partner

GHDX 10%
The future of predictive medicine

INCY 20%
JAK inhibitor for RA- as good as the biologics with the convenience of qd oral dosing

SRPT 20%
The DMD patients are clamoring for any efficacious treatment

VVUS 10%
Company should be sold this year unless Q sales ramp up dramatically

XOMA 10%
All about the Servier collaboration on gevokizumab and the partner is an expert in ACS

ZLCS 10%
Interesting pain programs, but very risky

I pledge $250 to the winner's specified charity.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext